Amicus, USPTO Urge Denial of Cellect SCOTUS PetitionInari urges the U.S. Supreme Court to uphold the Federal Circuit's Cellect decision, arguing it strengthens innovation incentives.
Allergan: En Banc Support for Stronger ODP RulesThe Federal Circuit created loopholes that undermine obviousness-type double patenting, posing challenges for generic competition and contradicting precedent.
Old Dog, New Tricks: Government Defends 200-Year-Old ODP Doctrine Even Under Modern StatutesThe Government defends the Federal Circuit's ruling that obviousness-type double patenting applies to Patent Term Adjusted patents, emphasizing historical and statutory support.
Amicus, USPTO Urge Denial of Cellect SCOTUS PetitionInari urges the U.S. Supreme Court to uphold the Federal Circuit's Cellect decision, arguing it strengthens innovation incentives.
Allergan: En Banc Support for Stronger ODP RulesThe Federal Circuit created loopholes that undermine obviousness-type double patenting, posing challenges for generic competition and contradicting precedent.
Old Dog, New Tricks: Government Defends 200-Year-Old ODP Doctrine Even Under Modern StatutesThe Government defends the Federal Circuit's ruling that obviousness-type double patenting applies to Patent Term Adjusted patents, emphasizing historical and statutory support.